SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. (2023)
Attributed to:
COVID-19 Genomics UK Consortium (COG-UK)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.91179
Publication URI: https://www.repository.cam.ac.uk/handle/1810/343758
Type: Journal Article/Review